Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Washington University School of Medicine
Eli Lilly and Company
M.D. Anderson Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
National Institutes of Health Clinical Center (CC)
Janssen Pharmaceutical K.K.
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Incyte Corporation
Baylor College of Medicine
M.D. Anderson Cancer Center
AstraZeneca
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
Canadian Cancer Trials Group
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
University of California, Davis
Dana-Farber Cancer Institute
Emory University
Emory University
Radiation Therapy Oncology Group
Eli Lilly and Company
University of Colorado, Denver
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Kentucky
Exelixis
Dana-Farber Cancer Institute
Exelixis
Merck Sharp & Dohme LLC
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Washington University School of Medicine
Eli Lilly and Company
Dana-Farber Cancer Institute
University of Cincinnati